Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Immunotherapy for Brain Metastases from Lung Cancer
NCT01782287Phase 3Unknown
- Sponsor
- NeuroVita Clinic
- Start
- Dec 2012
- Primary completion
- Dec 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of hematopoietic stem cells in lung cancer, brain metastasis (BM), sponsored by NeuroVita Clinic. Status: unknown.
02
Drugs
hematopoietic stem cells
03
Conditions
lung cancerbrain metastasis (BM)
Beyond the preview
Go deeper on NCT01782287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782287.